Visceral abnormalities occurred in blood vessels, lung, liver, and esophagus
Dual GLP-1/glucagon receptor agonists, including mazdutide, integrate appetite suppression with increased energy expenditure and fat oxidation, while triple GLP-1/GIP/glucagon agonists, such as retatrutide, further augment these mechanisms through multi-pathway receptor engagement
He also shares educational content on social media @michaelalbertmd, where he reaches more than 300,000 followers across platforms, fostering a more informed, compassionate conversation about obesity
Therefore, you might have symptoms such as weak muscles, numbness, trouble walking, nausea, weight loss, irritability, fatigue, and increased heart rate
& Mizuno, T